Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ·Healthcare·Biotechnology
$3.05
+4.10%
Mkt Cap $5.67M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | $100.00K | $100.00K | +0.00% | -$0.38 | -$0.19 | +50.00% | — | — |
| Q1 2026 Mar 25, 2026 | $100.00K | $100.00K | +0.00% | -$0.38 | -$0.38 | +0.00% | — | — |
| Q4 2025 Nov 12, 2025 | — | $875.00K | — | — | -$0.30 | — | — | — |
| Q3 2025 Aug 5, 2025 | — | $93.00K | — | — | -$0.11 | — | — | — |
| Q2 2025 May 6, 2025 | — | $81.00K | — | — | -$0.56 | — | — | — |
| Q1 2025 Mar 4, 2025 | — | $1.81M | — | — | $0.22 | — | — | — |
| Q4 2024 Nov 14, 2024 | — | $194.00K | — | — | -$0.29 | — | — | — |
| Q1 2024 Mar 5, 2024 | $608.00K | — | — | -$7.40 | -$0.68 | +90.75% | — | — |
| Q4 2023 Nov 13, 2023 | $608.00K | — | — | -$6.40 | -$0.93 | +85.47% | — | — |
| Q3 2023 Jul 28, 2023 | $608.00K | — | — | -$5.60 | -$1.83 | +67.32% | — | — |
| Q2 2023 May 11, 2023 | $608.00K | — | — | -$6.00 | -$3.20 | +46.67% | — | — |
| Q1 2023 Mar 22, 2023 | $608.00K | $1.63M | +167.27% | -$5.80 | -$3.20 | +44.83% | — | — |
| Q4 2022 Nov 3, 2022 | $153.00K | — | — | -$7.00 | -$4.80 | +31.43% | — | — |
| Q3 2022 Aug 9, 2022 | $355.50K | $72.00K | -79.75% | -$6.80 | -$6.20 | +8.82% | — | — |
| Q2 2022 May 4, 2022 | $550.00K | $225.00K | -59.09% | -$7.20 | -$6.00 | +16.67% | — | — |
| Q1 2022 Feb 24, 2022 | $900.00K | $182.00K | -79.78% | -$6.40 | -$4.80 | +25.00% | — | — |
| Q4 2021 Nov 9, 2021 | $384.00K | $77.00K | -79.95% | -$5.80 | -$5.20 | +10.34% | — | — |
| Q3 2021 Jul 29, 2021 | — | $3.00M | — | — | -$9.00 | — | — | — |
| Q2 2021 Apr 30, 2021 | — | $62.00K | — | — | -$7.86 | — | — | — |
| Q1 2021 Feb 25, 2021 | $112.00K | $133.00K | +18.75% | -$0.19 | -$11.00 | -5689.47% | — | — |